Network origin in Franco de Vecchi first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Helsinn Therapeutics (U.S.), Inc.
 Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Franco de Vecchi via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| KAZIA THERAPEUTICS LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
Sapphire Therapeutics, Inc.
 Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Southern Methodist University
 Southern Methodist University Other Consumer ServicesConsumer Services Southern Methodist University is a private university near the center of Dallas, SMU offers undergraduate, graduate, and professional programs through seven schools in the humanities and sciences, business, the performing, visual, and communication arts, engineering, education and human development, law, and theology. | College/University | Undergraduate Degree | |
| Stanford University | College/University | Doctorate Degree | |
| Rice University | College/University | Masters Business Admin | |
Shell Chemicals Ltd.
 Shell Chemicals Ltd. Chemicals: SpecialtyProcess Industries Shell Chemicals Ltd. manufactures basic organic and inorganic chemicals. Its products include alpha olefins, aromatics, corterra, ethylene oxide, lower olefins, solvents, and propylene oxide. The company was founded in 1929 and is headquartered in London, UK. | Chemicals: Specialty | Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer | |
| Robert Wood Johnson Medical School | College/University | Doctorate Degree | |
| CELLECTAR BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Druggability Technologies Holdings Ltd. (New Jersey) | Chief Tech/Sci/R&D Officer | ||
| BRII BIOSCIENCES LIMITED | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer |
Statistics
International
| United States | 11 |
| Australia | 2 |
| United Kingdom | 2 |
| China | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 5 |
| Process Industries | 2 |
| Finance | 2 |
| Commercial Services | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 7 |
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 2 |
| Doctorate Degree | 2 |
| Chief Operating Officer | 1 |
Most connected contacts
| Insiders | |
|---|---|
| Eleanor de Groot | 9 |
| John Friend | 6 |
- Stock Market
- Insiders
- Franco de Vecchi
- Company connections
